EnzyTag technology

Our technology offers an entry into linear and cyclic peptide drugs, small proteins, (bio)conjugates, Antibody Drug Conjugates, PROTACs and LYTACs.

Representative Examples

News

Read our latest news and stay updated

EFMC

EnzyTag to attend the virtual EFMC conference September 10 – 11, 2020.

Go To News

Please feel free to contact us

EnzyTag is open to further discussions on technology licensing for commercial purposes.

CONTACT US NOW